Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest (NCT03261232) | Clinical Trial Compass
CompletedNot Applicable
Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest
France65 participantsStarted 2016-03
Plain-language summary
Through this retrospective observational study (over 4 years; period analysed: 1st January 2011 to 31st December 2014), we looked for prognostic factors associated with better survival in refractory cardiac arrest by:
* assessing the overall survival rate
* evaluating the frequency of intra et extra-hospital events and by comparing these with the survival rate
* studying no flow, low flow, rhythm at initial management, troponinemia, lactatemia and blood pH in the different groups.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with in-hospital or out-of-hospital refractory CA who underwent ECLS
Exclusion Criteria:
* CA occurring during cardiac surgery
* Age \> 75 years or \< 18 years
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this study has already been completed and was looking at survival and death rates in refractory cardiac arrest patients treated with extracorporeal life support, has my doctor seen the findings, and do those findings change how they would approach my situation?
2Because this was an observational study searching for prognostic factors rather than testing a new treatment, what does it actually mean for my care — does it help predict whether ECLS would be likely to help someone in my specific circumstances?
3The study focused on 'refractory' cardiac arrest, meaning cases where standard resuscitation hasn't worked — at what point would my doctor consider my situation to meet that definition, and is ECLS even an option at the hospitals involved in my care?
4If this research has identified certain prognostic factors linked to better survival, does my doctor think I would have those factors, and how much weight should I give that information when deciding about treatment options?
5Are there standard treatments or other clinical trials my doctor would recommend considering alongside or instead of the ECLS approach that this study was evaluating?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.